Photo taken on Dec. 28, 2020 shows a press conference held by the National Healthcare Security Administration (NHSA) in Beijing, capital of China. China has included 119 more kinds of drugs in its national medical insurance reimbursement list, delivering greater price cuts and benefiting more people, the National Healthcare Security Administration (NHSA) said at a press conference Monday. Ninety-six of the new additions to the list are exclusive drugs that offer lower prices through negotiation and 16 were newly put on the market this year, the NHSA said. (Xinhua/Zhang Yuwei)
